Skip to content
★ Sign in to follow
Insider activity · 24 months0 buys5 salesCumulative net flow
Total declarations
17
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (11 ops.)
€541k

Latest filing published 19 Mar 2026 for Stoke Therapeutics, Inc., €27k.

Filing timeline

BuySale
Thomas Leggett

Insider track record

Disclosed buys
0
Disclosed sells
11
Signal history

Thomas Leggett: trading record in brief

This profile gathers the share dealings of Thomas Leggett across 2 companies, led by Black Diamond Therapeutics, Inc. and Stoke Therapeutics, Inc. We count 17 filings; the first trade dates from 14 September 2020 and the latest from 18 March 2026.

Sales make up the whole of the open-market record (11 sales, €541k). Besides market trades, the filings include 6 option exercises. 2026 to date brings no purchases and 5 sales.

On 19 March 2026 came the latest disclosure, an open-market sale for €27k in Stoke Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Thomas Leggett

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total

17 of 17 declarations